These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 22545289)

  • 1. Tumour immunotherapy--leukocytes take up the fight.
    Alderton GK; Bordon Y
    Nat Rev Immunol; 2012 Apr; 12(4):237. PubMed ID: 22545289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate immune mediators in cancer: between defense and resistance.
    Berraondo P; Minute L; Ajona D; Corrales L; Melero I; Pio R
    Immunol Rev; 2016 Nov; 274(1):290-306. PubMed ID: 27782320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invariant natural killer T cells in immune surveillance and tumor immunotherapy: perspectives and potentials.
    Haeryfar SM
    Arch Iran Med; 2008 Mar; 11(2):186-95. PubMed ID: 18298297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An introduction to tumour immunology.
    James K
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically modified immune cells for cancer immunotherapy.
    Jiang L; Wang W
    Sci China Life Sci; 2018 Oct; 61(10):1277-1279. PubMed ID: 30276708
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immune system and tumors].
    Terme M; Tanchot C
    Ann Pathol; 2017 Feb; 37(1):11-17. PubMed ID: 28159405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-class cancer therapeutic to stimulate natural killer cells.
    Sheridan C
    Nat Biotechnol; 2006 Jun; 24(6):597. PubMed ID: 16763573
    [No Abstract]   [Full Text] [Related]  

  • 8. From kinetics and cellular cooperations to cancer immunotherapies.
    Trautmann A
    Oncotarget; 2016 Jul; 7(28):44779-44789. PubMed ID: 27014912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour-induced immune suppression: role of inflammatory mediators released by myelomonocytic cells.
    Mao Y; Poschke I; Kiessling R
    J Intern Med; 2014 Aug; 276(2):154-70. PubMed ID: 24597954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanisms of tumor and immune system interaction].
    Berezhnoĭ AE; Gnuchev NV; Georgiev GP; Kozlov AM; Larin SS
    Vopr Onkol; 2008; 54(6):669-83. PubMed ID: 19241839
    [No Abstract]   [Full Text] [Related]  

  • 11. New cancer-fighting cells enter trials.
    Leslie M
    Science; 2018 Sep; 361(6407):1056-1057. PubMed ID: 30213892
    [No Abstract]   [Full Text] [Related]  

  • 12. Harnessing the power of Vδ2 cells in cancer immunotherapy.
    Fowler DW; Bodman-Smith MD
    Clin Exp Immunol; 2015 Apr; 180(1):1-10. PubMed ID: 25469879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Going back to class I: MHC and immunotherapies for childhood cancer.
    Haworth KB; Leddon JL; Chen CY; Horwitz EM; Mackall CL; Cripe TP
    Pediatr Blood Cancer; 2015 Apr; 62(4):571-6. PubMed ID: 25524394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New immune cell engagers for cancer immunotherapy.
    Fenis A; Demaria O; Gauthier L; Vivier E; Narni-Mancinelli E
    Nat Rev Immunol; 2024 Jul; 24(7):471-486. PubMed ID: 38273127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new approach to immunotherapy of cancer based on autologous T-lymphocytes].
    Dosne Pasqualini C; Laguens RP
    Medicina (B Aires); 1987; 47(3):307-12. PubMed ID: 3326997
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel costimulators in the immune gene therapy of cancer.
    Galea-Lauri J; Farzaneh F; Gäken J
    Cancer Gene Ther; 1996; 3(3):202-14. PubMed ID: 8725885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immune system and cancer evasion strategies: therapeutic concepts.
    Muenst S; Läubli H; Soysal SD; Zippelius A; Tzankov A; Hoeller S
    J Intern Med; 2016 Jun; 279(6):541-62. PubMed ID: 26748421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethical considerations of cellular immunotherapy for cancer.
    Ren SS; Deng JW; Hong M; Ren YL; Fu HJ; Liu YN; Chen Z
    J Zhejiang Univ Sci B; 2019 Jan.; 20(1):23-31. PubMed ID: 30614227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunotherapy of prostate and bladder cancer.
    Totterman TH; Loskog A; Essand M
    BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adoptive immunotherapy in the treatment of malignant disease.
    Klein HG; Leitman SF
    Transfusion; 1989 Feb; 29(2):170-8. PubMed ID: 2645696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.